Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay (original) (raw)
Evaluation of Cytochrome P450 Probe Substrates Commonly Used by the Pharmaceutical Industry to Study in Vitro Drug Interactions
Kellie Reynolds
Drug Metabolism and Disposition, 2002
View PDFchevron_right
The Utility of in Vitro Cytochrome P450 Inhibition Data in the Prediction of Drug-Drug Interactions
Larry Tremaine
Journal of Pharmacology and Experimental Therapeutics, 2005
View PDFchevron_right
Integrated in Vitro Analysis for the in Vivo Prediction of Cytochrome P450-Mediated Drug-Drug Interactions
James Tucker
Drug Metabolism and Disposition, 2008
View PDFchevron_right
Use of Cocktail Probe Drugs for Indexing Cytochrome P450 Enzymes in Clinical Pharmacology Studies – Review of Case Studies
Poonam Giri
Drug Metabolism Letters, 2019
View PDFchevron_right
A rapid ultra-performance liquid chromatography/tandem mass spectrometric methodology for the in vitro analysis of Pooled and Cocktail cytochrome P450 assays
Darcy Shave
Rapid Communications in Mass Spectrometry, 2010
View PDFchevron_right
Impact of Probe Substrate Selection on Cytochrome P450 Reaction Phenotyping Using the Relative Activity Factor
George Lai
Drug Metabolism and Disposition, 2016
View PDFchevron_right
Cytochrome P450 (CYP) inhibition screening: Comparison of three tests
Jouko Uusitalo
European Journal of Pharmaceutical Sciences, 2006
View PDFchevron_right
In vitro cytochrome P450 inhibition data and the prediction of drug-drug interactions: qualitative relationships, quantitative predictions, and the rank-order approach
Larry Tremaine
Clinical pharmacology and therapeutics, 2005
View PDFchevron_right
SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions
Stefan Guenther, Robert Preissner
Nucleic Acids Research, 2010
View PDFchevron_right
Contribution of Metabolites to P450 Inhibition-Based Drug-Drug Interactions: Scholarship from the IQ DMLG Metabolite Group
Chandra Agarwal
Drug metabolism and disposition: the biological fate of chemicals, 2015
View PDFchevron_right
Assessment of Cytochrome P450 Induction in Human Hepatocytes Using the Cocktail Strategy Plus Liquid Chromatography Tandem Mass Spectrometry
Jose Castell
Drug Metabolism Letters, 2008
View PDFchevron_right
A cocktail approach for assessing the in vitro activity of human cytochrome P450s: An overview of current methodologies
Youssef Daali
Journal of Pharmaceutical and Biomedical Analysis, 2014
View PDFchevron_right
Cytochrome P450 Part 3: Impact of Drug-Drug Interactions
Ross McKinnon
Journal of Pharmacy Practice and Research, 2009
View PDFchevron_right
Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids
Erin Berthold
Toxicology Letters, 2019
View PDFchevron_right
Use of inhibitory monoclonal antibodies to assess the contribution of cytochromes P450 to human drug metabolism
Tin-tin Lu
European Journal of Pharmacology, 2000
View PDFchevron_right
Mechanism-based inhibition of cytochrome P450 enzymes: An evaluation of early decision making in vitro approaches and drug–drug interaction prediction methods
Ken Grime
European Journal of Pharmaceutical Sciences, 2009
View PDFchevron_right
Highly sensitive LC–MS/MS methods for the determination of seven human CYP450 activities using small oral doses of probe-drugs in human
Sophie Gravel
Journal of Chromatography B, 2017
View PDFchevron_right
A Novel Model for the Prediction of Drug-Drug Interactions in Humans Based on in Vitro Cytochrome P450 Phenotypic Data
Lisa von Moltke
Drug Metabolism and Disposition, 2006
View PDFchevron_right
Determination of major human cytochrome P450s activities in 96-well plates using liquid chromatography tandem mass spectrometry
Jose Castell
Toxicology in Vitro, 2007
View PDFchevron_right
Rapid and quantitative determination of metabolites from multiple cytochrome P450 probe substrates by gradient liquid chromatography–electrospray ionization-ion trap mass spectrometry
Tianyi Zhang
Journal of Chromatography B-analytical Technologies in The Biomedical and Life Sciences, 2002
View PDFchevron_right
Simultaneous Determination of Cytochrome P450 Oxidation Capacity in Humans: A Review on the Phenotyping Cocktail Approach
Adrián LLerena, Fernando De Andres
View PDFchevron_right
An extensive cocktail approach for rapid risk assessment of in vitro CYP450 direct reversible inhibition by xenobiotic exposure
Youssef Daali
Toxicology and applied pharmacology, 2016
View PDFchevron_right
Application of a Substrate Cocktail Approach in the Assessment of Cytochrome P450 Induction Using Cultured Human Hepatocytes
George Lai
SLAS Discovery, 2012
View PDFchevron_right
A Novel Approach to Predicting P450 Mediated Drug Metabolism. CYP2D6 Catalyzed N-Dealkylation Reactions and Qualitative Metabolite Predictions Using a Combined Protein and Pharmacophore Model for CYP2D6
Alexander istia Alex
Journal of Medicinal Chemistry, 1999
View PDFchevron_right
Chromatographic assays of drug oxidation by human cytochrome P450 3A4
Christal Sohl
Nature Protocols, 2009
View PDFchevron_right
Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method
Youssef Daali
Basic & Clinical Pharmacology & Toxicology, 2016
View PDFchevron_right
A New Standardized Electrochemical Array for Drug Metabolic Profiling with Human Cytochromes P450
Ennio Capria
Analytical Chemistry, 2011
View PDFchevron_right
Cytochrome P450 Knock-Out Assay with Nonselective Inhibitors
Zhengyin Yan
2021
View PDFchevron_right
Prediction of Pharmacokinetic Drug-Drug Interactions Using Human Hepatocyte Suspension in Plasma and Cytochrome P450 Phenotypic Data. II. In Vitro-in Vivo Correlation with Ketoconazole
Chuang Lu
Drug Metabolism and Disposition, 2008
View PDFchevron_right
Clinically Important Drug Interactions Potentially Involving Mechanism-based Inhibition of Cytochrome P450 3A4 and the Role of Therapeutic Drug Monitoring
Charlie Xue
Therapeutic Drug Monitoring, 2007
View PDFchevron_right
Perpetrators of pharmacokinetic drug-drug interactions arising from altered cytochrome P450 activity: a criteria-based assessment
Matthew Doogue
British Journal of Clinical Pharmacology, 2011
View PDFchevron_right
The role of polymorphic cytochrome P450 enzymes in drug design, development and drug interactions with a special emphasis on phenotyping
Emel Arinc
J Mol Catal B Enzym, 2010
View PDFchevron_right
Common Approaches of Cytochrome P450 (CYP) Induction Assays
Ms. Rupali Ghosh
International Blood Research & Reviews
View PDFchevron_right